Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

E. Bryant, Juliet; S. Azman, Andrew; J. Ferrari, Matthew; F. Arnold, Benjamin; F. Boni, Maciej; Boum, Yap; Hayford, Kyla; J. Luquero, Francisco; J. Mina, Michael; Rodríguez-Barraquer, Isabel; T. Wu, Joseph; Wade, Djibril; Vernet, Guy; T. Leung, Daniel

doi:10.1126/sciimmunol.abc6347

Public

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Published in Science Immunology • May 19, 2020

Authors:

Juliet E. Bryant

Andrew S. Azman

Matthew J. Ferrari

Abstract

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).

Subject

Serology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!